Xiaobai Maimai Eyes Cancer Treatment as E-Commerce Pivot Sputters
Former P2P lender’s stock soared up to tenfold after announcement of latest shift, but later gave up much of the gains Key Takeaways: Xiaobai Maimai, the former P2P lender known…
RELATED ARTICLES
-
Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
A blockbuster cancer drug? TYK’s claims go under the microscope
2410.HK
-
NEWS WRAP: Hutchmed sells non-core asset to focus on cancer treatment
0013.HK HCM.US
- Cancer drug maker Genfleet joins Hong Kong IPO influx
-
Cango’s latest pivot uncovers gold in bitcoin mining
CANG.US
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
